share_log

Aveanna Healthcare Hldgs Analyst Ratings

Aveanna Healthcare Hldgs Analyst Ratings

雅安娜醫療保健控股分析師評級
Benzinga Analyst Ratings ·  2023/01/27 07:15
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/27/2023 -23.66% Credit Suisse $2 → $1 Downgrades Neutral → Underperform
11/21/2022 129.01% RBC Capital $7 → $3 Downgrades Outperform → Sector Perform
11/17/2022 52.67% Credit Suisse $5.5 → $2 Downgrades Outperform → Neutral
11/16/2022 205.34% Raymond James $6 → $4 Maintains Strong Buy
11/11/2022 14.5% Stephens & Co. $2.25 → $1.5 Maintains Equal-Weight
08/19/2022 281.68% Barclays $7 → $5 Maintains Overweight
08/15/2022 358.02% Raymond James $8 → $6 Maintains Strong Buy
07/22/2022 90.84% Jefferies $9 → $2.5 Downgrades Buy → Hold
07/05/2022 — Truist Securities Downgrades Buy → Hold
06/21/2022 167.18% Stephens & Co. $5.5 → $3.5 Downgrades Overweight → Equal-Weight
03/31/2022 510.69% Raymond James $12 → $8 Maintains Strong Buy
03/31/2022 587.02% RBC Capital $16 → $9 Maintains Outperform
03/30/2022 281.68% Truist Securities $10 → $5 Maintains Buy
03/30/2022 358.02% Deutsche Bank $12.5 → $6 Maintains Buy
03/30/2022 434.35% Stephens & Co. $11.5 → $7 Maintains Overweight
03/30/2022 434.35% Barclays $16 → $7 Maintains Overweight
03/30/2022 625.19% Credit Suisse $12 → $9.5 Maintains Outperform
03/29/2022 319.85% B of A Securities $10 → $5.5 Downgrades Buy → Neutral
11/23/2021 816.03% Raymond James $15 → $12 Maintains Strong Buy
05/24/2021 968.7% JP Morgan → $14 Initiates Coverage On → Neutral
05/24/2021 1045.04% Jefferies → $15 Initiates Coverage On → Buy
05/24/2021 1045.04% Raymond James → $15 Initiates Coverage On → Strong Buy
05/24/2021 930.53% Deutsche Bank → $13.5 Initiates Coverage On → Buy
05/24/2021 1121.37% Credit Suisse → $16 Initiates Coverage On → Outperform
05/24/2021 1197.71% BMO Capital → $17 Initiates Coverage On → Outperform
05/24/2021 1121.37% RBC Capital → $16 Initiates Coverage On → Outperform
05/24/2021 1426.72% Barclays → $20 Initiates Coverage On → Overweight
05/24/2021 1045.04% Truist Securities → $15 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
01/27/2023 -23.66% 瑞士信貸 $2 → $1 評級下調 中性→表現不佳
11/21/2022 129.01% 加拿大皇家銀行資本 $7 → $3 評級下調 跑贏→板塊表現
11/17/2022 52.67% 瑞士信貸 $5.5 → $2 評級下調 跑贏→中性
11/16/2022 205.34% 雷蒙德·詹姆斯 $6 → $4 維護 強勢購買
11/11/2022 14.5% 斯蒂芬斯公司 $2.25 → $1.5 維護 等重
08/19/2022 281.68% 巴克萊 $7 → $5 維護 超重
08/15/2022 358.02% 雷蒙德·詹姆斯 $8 → $6 維護 強勢購買
07/22/2022 90.84% 傑富瑞 $9 → $2.5 評級下調 購買→Hold
07/05/2022 — Truist證券 評級下調 購買→Hold
06/21/2022 167.18% 斯蒂芬斯公司 $5.5 → $3.5 評級下調 超重→等重
03/31/2022 510.69% 雷蒙德·詹姆斯 $12 → $8 維護 強勢購買
03/31/2022 587.02% 加拿大皇家銀行資本 $16 → $9 維護 跑贏大盤
03/30/2022 281.68% Truist證券 $10 → $5 維護 買
03/30/2022 358.02% 德意志銀行 $12.5 → $6 維護 買
03/30/2022 434.35% 斯蒂芬斯公司 $11.5 → $7 維護 超重
03/30/2022 434.35% 巴克萊 $16 → $7 維護 超重
03/30/2022 625.19% 瑞士信貸 $12 → $9.5 維護 跑贏大盤
03/29/2022 319.85% B of A證券 $10 → $5.5 評級下調 購買→中性
11/23/2021 816.03% 雷蒙德·詹姆斯 $15 → $12 維護 強勢購買
05/24/2021 968.7% 摩根大通 → $14 開始承保 →中性
05/24/2021 1045.04% 傑富瑞 → $15 開始承保 →購買
05/24/2021 1045.04% 雷蒙德·詹姆斯 → $15 開始承保 →強勢購買
05/24/2021 930.53% 德意志銀行 → $13.5 開始承保 →購買
05/24/2021 1121.37% 瑞士信貸 → $16 開始承保 →跑贏大盤
05/24/2021 1197.71% 蒙特利爾銀行資本 → $17 開始承保 →跑贏大盤
05/24/2021 1121.37% 加拿大皇家銀行資本 → $16 開始承保 →跑贏大盤
05/24/2021 1426.72% 巴克萊 → $20 開始承保 →超重
05/24/2021 1045.04% Truist證券 → $15 開始承保 →購買

What is the target price for Aveanna Healthcare Hldgs (AVAH)?

Aveanna Healthcare Hldgs(Avah)的目標價格是多少？

The latest price target for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was reported by Credit Suisse on January 27, 2023. The analyst firm set a price target for $1.00 expecting AVAH to fall to within 12 months (a possible -23.66% downside). 18 analyst firms have reported ratings in the last year.

瑞士信貸於2023年1月27日報告了Aveanna Healthcare Hldgs(納斯達克：AVA)的最新目標價。這家分析公司將目標價定為1.00美元，預計Avah將在12個月內下跌(可能下跌23.66%)。去年有18家分析公司公佈了評級。

What is the most recent analyst rating for Aveanna Healthcare Hldgs (AVAH)?

Aveanna Healthcare Hldgs(Avah)的最新分析師評級是多少？

The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was provided by Credit Suisse, and Aveanna Healthcare Hldgs downgraded their underperform rating.

瑞士信貸對Aveanna Healthcare Hldgs(納斯達克代碼：AVA)的最新分析師評級，Aveanna Healthcare Hldgs下調了其表現不佳的評級。

When is the next analyst rating going to be posted or updated for Aveanna Healthcare Hldgs (AVAH)?

Aveanna Healthcare Hldgs(Avah)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on January 27, 2023 so you should expect the next rating to be made available sometime around January 27, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Aveanna Healthcare Hldgs的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Aveanna Healthcare Hldgs的上一次評級是在2023年1月27日提交的，所以你應該預計下一次評級將在2024年1月27日左右的某個時候提供。

Is the Analyst Rating Aveanna Healthcare Hldgs (AVAH) correct?

分析師對Aveanna Healthcare Hldgs(Avah)的評級正確嗎？

While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a downgraded with a price target of $2.00 to $1.00. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $1.31, which is out of the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Aveanna Healthcare Hldgs(Avah)評級被下調，目標價為2.00美元至1.00美元。Aveanna Healthcare Hldgs(Avah)目前的股價為1.31美元，超出了分析師的預測區間。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論